Home/Filings/4/0001209191-21-036254
4//SEC Filing

Stewart Christopher P. 4

Accession 0001209191-21-036254

CIK 0001411690other

Filed

May 26, 8:00 PM ET

Accepted

May 27, 4:36 PM ET

Size

7.3 KB

Accession

0001209191-21-036254

Insider Transaction Report

Form 4
Period: 2021-05-26
Stewart Christopher P.
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-05-26$0.56/sh+25,000$14,00033,000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-05-2625,000200,000 total
    Exercise: $0.56Exp: 2030-09-01Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person.

Issuer

Bionano Genomics, Inc

CIK 0001411690

Entity typeother

Related Parties

1
  • filerCIK 0001822991

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:36 PM ET
Size
7.3 KB